Ludocare Information

Created in 2017 in Lyon, Ludocare develops evidence-based digital therapies for the benefit of patients, those around them and healthcare professionals. ✅ Its objective: better control of the disease and stabilization of basic treatment, to improve the quality of life of children with chronic illnesses. 💡The medical purpose of JOE digital therapy is to improve asthma control through better use of inhalation devices and increased compliance with drug treatments, and thus preventively reduce attacks and exacerbations. ➡️ To date, Ludocare is part of a scientific approach to demonstrate the medical benefits of Joe digital therapy via the establishment of a clinical investigation on French territory. Ludocare's desire is to benefit from the results of the clinical study to develop in France and internationally. 🇫🇷 Ludocare’s solutions are produced in France, quality being part of the company’s DNA and “Made in France” being the guarantor. The Joe solution is in compliance with the GDPR, this digital therapy meets the standards for the management of health data collected and secured by a certified host in France. Digital therapy JOE is a Class I medical device in accordance with the requirements of Regulation (EU) 2017/745, and carries under this regulation, the CE mark. Since June 2023, Ludocare is certified NF EN ISO 13485:2016/A11:2021.